How to read the Mounjaro dosage chart
Each row is one weekly dose. Mounjaro always starts at 2.5 mg, and every increase follows one rule: add 2.5 mg, and only after at least four weeks on the dose you’re on (Mounjaro prescribing information; UK patient leaflet). That’s why the earliest anyone could reach 15 mg is week 21.
In practice, the climb is usually slower, and it often stops earlier. Your prescriber may keep you on a dose longer if side effects are bothering you, or stop at a dose that already works. You don’t have to reach 15 mg. Since August 2026 the US label also allows 2.5 mg as an ongoing dose for blood-sugar control, not only as a starting dose. In children 10 and older, the maximum is 10 mg.
What each dose did in the weight-loss trial
In SURMOUNT-1, adults with obesity and without diabetes were assigned one maintenance dose of tirzepatide, the medicine in Mounjaro, and stayed on it (Jastreboff et al., NEJM 2022):
| Dose | Average weight lost after 72 weeks |
|---|---|
| 5 mg | 15.0% |
| 10 mg | 19.5% |
| 15 mg | 20.9% |
| Placebo | 3.1% |
These are averages alongside diet and exercise advice, and individual results vary a lot. They also show why stopping at 5 or 10 mg can be a reasonable choice.
The KwikPen: one pen, one dose, one month
In the UK, Mounjaro comes as a KwikPen, and the US label includes one too. Each pen holds four weekly doses of one strength (UK patient leaflet):
- One pen lasts a month. Four doses, one a week. When your dose changes, you move to the KwikPen of the new strength, not to more pens.
- 30 days after first use. An opened KwikPen can be kept at up to 30 °C and is discarded after 30 days, even if a dose is left. Unopened pens go in the refrigerator at 2–8 °C.
- Don’t use what’s left. The leaflet says not to try to use any medicine left in the pen after the four doses.
About clicks. Online, especially in UK forums, people share click charts to squeeze an extra dose out of a KwikPen or to take a “golden dose” between two strengths. That isn’t in the leaflet, which tells you not to use leftover medicine, and Lilly says splitting tirzepatide doses hasn’t been studied and isn’t recommended (Lilly Medical). If a full step feels like too much, that’s a conversation for your prescriber.
In the US, Mounjaro also comes in single-dose pens and vials, which can be kept unrefrigerated up to 30 °C (86 °F) for a total of 21 days. Inject under the skin of the abdomen or thigh, or the back of the upper arm if someone else gives the shot, and rotate the site each week.
When a dose is hard to tolerate
Digestive side effects are the main reason for the four-week steps, and they rise with the dose. In the placebo-controlled type 2 diabetes trials, nausea affected 12% of people on 5 mg, 15% on 10 mg and 18% on 15 mg, against 4% on placebo (Mounjaro prescribing information). The week after each step-up is the one to watch.
The usual order of steps is to change how you eat first (smaller meals, stop when full, less fatty food), then stay on your current dose longer, then go back to the previous dose for a while. The tirzepatide dosage chart covers this in detail, with the warning signs that need a prompt call. Our Mounjaro side effects guide lists the side effects by dose.
Missed doses and changing your shot day
| Situation | What to do |
|---|---|
| 4 days (96 hours) or less since the missed day | Take it as soon as possible |
| More than 4 days | Skip it; take the next dose on your usual day |
| Moving your shot day | Allowed if the two doses are at least 3 days (72 hours) apart |
| Missed several weeks in a row | No rule in the labels; ask your prescriber which dose to restart on |
Never take two doses within three days of each other. For longer breaks, the tirzepatide trials restarted people at the same dose after one or two missed doses, and at 5 mg after three or more (Lilly Medical). That’s trial practice, not a label instruction.
Mounjaro in the US, the UK and the EU
The dose steps are the same everywhere: 2.5 mg to start, 2.5 mg increases, 15 mg maximum (EMA product information). What differs is the approval. In the US, Mounjaro is approved for type 2 diabetes, and the weight-management version of tirzepatide is sold as Zepbound (see the Zepbound dosage chart). In the UK and EU, Mounjaro is also authorised for weight management in adults with a BMI of 30 or more, or 27 to under 30 with at least one weight-related health problem (MHRA).
Before surgery, during pregnancy, and with the pill
- Surgery or sedation: tell the team doing any planned operation under anaesthesia that you take Mounjaro.
- Birth control pills: tirzepatide can make them less effective. The labels advise switching to a non-oral method, or adding a barrier method, for four weeks after starting and for four weeks after each dose increase. Writing down the date of every step makes that easy to follow.
- Pregnancy: talk to your prescriber before trying to conceive, or as soon as you find out you’re pregnant.
Keeping a record of each step
Six possible doses, a new pen strength at each change, and a birth-control window after every increase add up to a lot of dates. In Mingo, every shot is saved with its dose, the weight chart marks the first shot of each new dose, and side effects are rated from 0 to 10 on the same timeline. Mingo doesn’t decide when you move up a dose; it keeps the record you and your prescriber decide with. Note the date you opened each KwikPen in the shot’s notes, so you know when its 30 days are up.


